当前位置: X-MOL 学术Breast Cancer Res. Treat. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasis.
Breast Cancer Research and Treatment ( IF 3.8 ) Pub Date : 2020-01-10 , DOI: 10.1007/s00198-019-05160-x
D Simon 1 , J Haschka 2, 3 , C Muschitz 2 , A Kocijan 4 , A Baierl 5 , A Kleyer 1 , G Schett 1 , S Kapiotis 6 , H Resch 2, 3, 7 , M Sticherling 8 , J Rech 1 , R Kocijan 2, 3
Affiliation  

We analyzed volumetric bone mineral density (vBMD) and bone microstructure using HR-pQCT in subjects with normouricemia (NU) and subjects with hyperuricemia (HU) with and without psoriasis (PSO). HU was associated with higher cortical vBMD and thickness. Differences in average and trabecular vBMD were found between patients with PSO + HU and NU. INTRODUCTION Hyperuricemia (HU) and gout are co-conditions of psoriasis and psoriatic arthritis. Current data suggest a positive association between HU and areal bone mineral density (BMD) and a negative influence of psoriasis on local bone, even in the absence of arthritis. However, the influence of the combination of HU and psoriasis on bone is still unclear. The aim of this study was to assess the impact of HU with and without psoriasis on bone microstructure and volumetric BMD (vBMD). METHODS Healthy individuals with uric acid levels within the normal range (NU), with hyperuricemia (HU), patients with hyperuricemia and psoriasis (PSO + HU), and patients with uric acid within the normal range and psoriasis (PSO + NU) were included in our study. Psoriasis patients had no current or past symptoms of arthritis. Average, trabecular, and cortical vBMD (mgHA/cm3); trabecular number (Tb.N, 1/mm) and thickness (Tb.Th, mm); inhomogeneity of the network (1/N.SD, mm); and cortical thickness (Ct.Th., mm) were carried out at the ultradistal radius using high-resolution peripheral quantitative computed tomography. In addition, bone turnover markers such as DKK-1, sclerostin, and P1NP were analyzed. RESULTS In total, 130 individuals were included (44 NU participants (34% female), 50 HU (24%), 16 PSO + HU (6%), 20 PSO + NU (60%)). Subjects were aged: NU 54.5 (42.8, 62.1), HU 57.5 (18.6, 65.1), PSO + HU 52.0 (42.3, 57.8), and PSO + NU 42.5 (34.8, 56.8), respectively. After adjusting for age, sex, BMI, and diabetes, patients in the HU group revealed significantly higher values of cortical vBMD (p < 0.001) as well as cortical thickness (p = 0.04) compared to the NU group. PSO + NU showed no differences to NU, but PSO + HU demonstrated both lower average (p = 0.03) and trabecular vBMD (p = 0.02). P1NP was associated with average, cortical, and trabecular vBMD as well as cortical thickness while sclerostin levels were related to trabecular vBMD. CONCLUSION Hyperuricemia in otherwise healthy subjects was associated with a better cortical vBMD and higher cortical thickness. However, patients with both psoriasis and hyperuricemia revealed a lower vBMD.

中文翻译:

高尿酸血症伴或不伴牛皮癣的患者的骨微结构和骨矿物质密度。

我们分析了正常尿酸血症(NU)和高尿酸血症(HU)伴和不伴牛皮癣(PSO)的受试者中使用HR-pQCT分析的骨密度和骨微结构。HU与更高的皮质vBMD和厚度相关。PSO + HU和NU患者之间的平均和小梁vBMD存在差异。简介高尿酸血症(HU)和痛风是牛皮癣和牛皮癣关节炎的共同病状。目前的数据表明,即使在没有关节炎的情况下,HU与面骨矿物质密度(BMD)之间也存在正相关,而牛皮癣对局部骨骼也有负面影响。但是,HU和牛皮癣的组合对骨骼的影响仍不清楚。这项研究的目的是评估带或不带牛皮癣的HU对骨微结构和体积BMD(vBMD)的影响。方法纳入尿酸水平在正常范围(NU),高尿酸血症(HU),高尿酸血症和牛皮癣(PSO + HU)患者以及尿酸在正常范围和牛皮癣(PSO + NU)范围内的健康个体在我们的研究中。牛皮癣患者没有当前或过去的关节炎症状。平均,小梁和皮质vBMD(mgHA / cm3);骨小梁数(Tb.N,1 / mm)和厚度(Tb.Th,mm); 网络不均匀(1 / N.SD,mm);使用高分辨率外围定量计算机断层扫描在超远半径处进行皮层厚度(Ct.Th.,mm)。此外,还分析了骨转换标记物,例如DKK-1,硬化蛋白和P1NP。结果总共包括130个人(44名NU参与者(女性34%),50名HU(24%),16名PSO + HU(6%),20名PSO + NU(60%))。受试者年龄分别为:NU 54.5(42.8,62.1),HU 57.5(18.6,65.1),PSO + HU 52.0(42.3,57.8)和PSO + NU 42.5(34.8,56.8)。在对年龄,性别,BMI和糖尿病进行调整后,与NU组相比,HU组患者的皮质vBMD值(p <0.001)和皮质厚度(p = 0.04)明显更高。PSO + NU与NU无差异,但PSO + HU均显示较低的平均值(p = 0.03)和小梁vBMD(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。62.1),HU 57.5(18.6、65.1),PSO + HU 52.0(42.3、57.8)和PSO + NU 42.5(34.8、56.8)。在对年龄,性别,BMI和糖尿病进行调整后,与NU组相比,HU组患者的皮质vBMD值(p <0.001)和皮质厚度(p = 0.04)明显更高。PSO + NU与NU无差异,但PSO + HU均显示较低的平均值(p = 0.03)和小梁vBMD(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。62.1),HU 57.5(18.6、65.1),PSO + HU 52.0(42.3、57.8)和PSO + NU 42.5(34.8、56.8)。在对年龄,性别,BMI和糖尿病进行调整后,与NU组相比,HU组患者的皮质vBMD值(p <0.001)和皮质厚度(p = 0.04)明显更高。PSO + NU与NU无差异,但PSO + HU均显示较低的平均值(p = 0.03)和小梁vBMD(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。和PSO + NU 42.5(34.8,56.8)。在对年龄,性别,BMI和糖尿病进行调整后,与NU组相比,HU组患者的皮质vBMD值(p <0.001)和皮质厚度(p = 0.04)明显更高。PSO + NU与NU无差异,但PSO + HU均显示较低的平均值(p = 0.03)和小梁vBMD(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。和PSO + NU 42.5(34.8,56.8)。调整年龄,性别,BMI和糖尿病后,HU组患者的皮质vBMD(p <0.001)和皮质厚度(p = 0.04)显着高于NU组。PSO + NU与NU无差异,但PSO + HU均显示较低的平均值(p = 0.03)和小梁vBMD(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。与NU组相比,HU组患者的皮质vBMD值(p <0.001)和皮质厚度(p = 0.04)明显更高。PSO + NU与NU无差异,但PSO + HU均显示较低的平均值(p = 0.03)和小梁vBMD(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。与NU组相比,HU组患者的皮质vBMD值(p <0.001)和皮质厚度(p = 0.04)明显更高。PSO + NU与NU无差异,但PSO + HU均显示较低的平均值(p = 0.03)和小梁vBMD(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。但PSO + HU的平均水平较低(p = 0.03),小梁vBMD较低(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。但PSO + HU的平均水平较低(p = 0.03),小梁vBMD较低(p = 0.02)。P1NP与平均,皮质和小梁vBMD以及皮质厚度相关,而硬化素水平与小梁vBMD相关。结论在其他健康受试者中,高尿酸血症与更好的皮质vBMD和更高的皮质厚度有关。然而,牛皮癣和高尿酸血症患者均显示出较低的vBMD。
更新日期:2020-04-20
down
wechat
bug